Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life (Q35171059)

6 August 2017

Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life (English)

1 reference

6 August 2017

1 reference

1 reference

1 reference

2

Karin Nielsen-Saines

1 reference

6 August 2017

Jack Moye

7

0 references

Lynne Mofenson

object named as

Lynne Mofenson

9

0 references

Jose Henrique Pilotto

3

object named as

Jose Henrique Pilotto

1 reference

6 August 2017

11

D Heather Watts

1 reference

6 August 2017

10

Margaret Camarca

1 reference

6 August 2017

8

Yvonne Bryson

1 reference

6 August 2017

1

Mark Mirochnick

1 reference

6 August 2017

Jorge Pinto

4

1 reference

6 August 2017

Valdilea Gonçalves Veloso

5

1 reference

6 August 2017

Steven Rossi

6

1 reference

6 August 2017

NICHD HPTN 040/PACTG 1043 PROTOCOL Team

12

1 reference

6 August 2017

1 September 2011

1 reference

Pediatric Infectious Disease Journal

6 August 2017

1 reference

6 August 2017

30

1 reference

6 August 2017

9

1 reference

6 August 2017

769-772

1 reference

Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Nevirapine concentrations in newborns receiving an extended prophylactic regimen

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Dose-escalating study of the safety and pharmacokinetics of nelfinavir in HIV-exposed neonates

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3158246

10.1097/INF.0B013E3182242950

27 September 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference